December 2022 - Page 17 of 22

ThursdayDec 08, 2022 9:45 am

Improving Loan Origination Landscape is Positive News for Mortgage Loan Clients, Mortgage Loan Facilitator REZYFi, Inc.

Miami-based REZYFi is a mortgage lender working with traditional loans but focusing particular attention on unbanked market sectors such as the cannabis industry and those property companies that provide leases to those sectors The loan origination industry appears to be experiencing a new round of greening in reversal of the year’s difficulties In the wake of positive CPI data last month, analysts are beginning to anticipate a greening of mortgage lending rates once inflationary pressures are reduced, making it easier for companies to obtain loans for their projects The greening of inflation news last month is important news for market…

ThursdayDec 08, 2022 9:00 am

SideChannel Inc. (SDCH) Ability To Make Powerful Cybersecurity Accessible For Small and Mid-sized Companies Results In 64% to 71% Year-Over-Year Revenue Increase

Services provided by SideChannel include CISO, vCPO, risk assessment and management, plus cybersecurity compliance SideChannel announced preliminary revenue reached $4.6 to $4.8 million for the fiscal year ending September 30, 2022, representing a significant YOY increase The global cybersecurity market size is expected to grow from an estimated $173.5 billion in 2022 to $266.2 billion by 2027, growing at a CAGR of 8.9% during the forecast period With a mission to make cybersecurity simple and accessible, SideChannel’s (OTCQB: SDCH) belief is that small and mid-sized organizations deserve the expertise of an experienced CISO (Chief Information Security Officer), just as much…

WednesdayDec 07, 2022 2:42 pm

QualityStocksNewsBreaks – MetAlert Inc. (MLRT) Featured in Research Report

Ludlow Research has announced that it updated its research opinion on MetAlert (OTC: MLRT), a pioneer in location-sensitive health monitoring devices and wearable technology products for remote patient monitoring. The update is based on MetAlert’s elimination of toxic debt, as well as the launch of new medical device products for cognitive markets. “Toxic debt, or variable convertible notes, are a form of debt, which sometimes convert at deep discounts to market price, and are major contributors to shareholder dilution and price instability for small issuers. In recent months, MetAlert extinguished all of their toxic convertible notes from their balance sheet,…

WednesdayDec 07, 2022 2:20 pm

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Deploys K1 Technology for Three New Contracts

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots, has announced three new contracts consisting of 13 new K1 Blue Light Towers and three K1 Retrofit Kits. Two of the new clients are colleges located in Georgia and Texas, marking education as a significant growth sector for the company. The announcement reads, “Knightscope’s K1 Blue Light Emergency Towers and emergency communication Retrofit Kits serve to deter potential negative activities using cellular and satellite communications with solar power to provide additional safety in remote locations. These newer, more advanced wireless systems will save colleges money on both infrastructure and hardware…

WednesdayDec 07, 2022 12:53 pm

QualityStocksNewsBreaks – Advanced Container Technologies Inc.’s (ACTX) GrowPods Return Local Control, Improve Food Quality

Advanced Container Technologies (OTC: ACTX) offers unique controlled environment farms called GrowPods, which can help reduce the environmental impact of traditional farming and enable year-round cultivation of nutritious food. According to a report republished in Science Direct, “hydroponic closed-environment agriculture could play a role in positive food system transformation, reducing environmental footprints, sparing land, and potentially helping to reconnect consumers with producers.” Further, according to Forbes, large volumes of greens are being grown indoors, even from retail giants, and controlled environmental agriculture is catching on and increasing in popularity. Doug Heldoorn, CEO of ACTX, said GrowPods are transportable and scalable,…

WednesdayDec 07, 2022 12:34 pm

QualityStocksNewsBreaks – Vision Energy Corp. (VENG) Announces Symbol Change

Vision Energy (OTCQB: VENG) has announced that, effective at the open of market trading today, its ticker symbol changed from VIHDD to VENG, completing previously reported corporate actions of the company (see news release dated Nov. 7, 2022). According to the update, no action is required by existing shareholders with respect to the ticker symbol change. The company’s common stock will continue trading on the OTCQB, and the CUSIP will remain unchanged. To view the full press release, visit https://ibn.fm/BJzfe About Vision Energy Corp. Vision Energy is a forward-looking energy company developing assets and solutions for the commercial, industrial and…

WednesdayDec 07, 2022 12:23 pm

QualityStocksNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Signs Agreement to Build Exclusive AIMIGo 12-Lead 3D VECG Device

HeartBeam (NASDAQ: BEAT), a cardiac technology company that has developed the first and only 3D-vector electrocardiogram (“VECG”) platform for heart attack detection anytime, anywhere, is partnering with medical device manufacturing company Evolve Manufacturing Technologies to build its credit-card-sized AIMIGo(TM) 3D vector electrocardiogram (“VECG”) recording device; the device is designed to provide a 12-lead ECG readout to detect heart attacks remotely. According to the announcement, HeartBeam will leverage Evolve’s manufacturing and packaging expertise as it focused on commercializing its HeartBeam AIMIGo device; the company expects to receive FDA clearance for the device in early 2023 and will then begin early market…

WednesdayDec 07, 2022 11:58 am

QualityStocksNewsBreaks – India Globalization Capital Inc. (NYSE American: IGC) Applauds Milestone Development for Medical Cannabis Industry

India Globalization Capital (NYSE American: IGC) applauds the signing of the Medical Marijuana and Cannabidiol Research Expansion Act, which was signed into law by President Biden on Friday Dec. 2, 2022. The legislation establishes a new registration process for conducting research on marijuana and for manufacturing marijuana products for research purposes and drug development. “The study and development of cannabis for its potential therapeutic benefits is at the center of our work at IGC-Pharma,” said Ram Mukunda, CEO of IGC. “For many years, onerous federal barriers have made it difficult to efficiently source and study cannabis for pharmaceutical applications. We…

WednesdayDec 07, 2022 11:49 am

QualityStocksNewsBreaks – CubCrafters Inc. Featured in Kitplanes Article

CubCrafters, the leading designer and manufacturer of light-sport, experimental and Part 23 certified backcountry aircraft, was featured in a recent article published by Kitplanes Magazine. The piece, written by Marc Cook, discusses the company’s development and design of the CubCrafters EX-2 CC363i. “Product development has many mothers. Sometimes you create a new airplane for a particular set of missions. Sometimes you take that design and tweak it based on customer feedback, advances in manufacturing capability or simply to crank up your market share and get your brand some juicy press coverage. And sometimes necessity is the driver,” reads the article.…

WednesdayDec 07, 2022 11:03 am

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Presents CYB003 Preclinical Data Amongst Leading Scientists, Academics in Neuropsychopharmacology

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), announced that it presented two posters on its deuterated psilocybin analog, CYB003, at the American College of Neuropsychopharmacology (“ACNP”) annual meeting taking place Dec. 4-7, 2022, in Phoenix, Arizona. According to the update, the data, including new pharmacokinetics (“PK”) findings, further strengthen the therapeutic profile of CYB003 as a novel treatment for major depressive disorder (“MDD”). “These new findings demonstrate the unique PK properties of CYB003 compared with classical psilocybin and further supports our ongoing first-in-human phase 1/2a clinical trial evaluating CYB003 for the treatment…

Site Search

Company Search

Month: December 2022